Downregulated expression of genes mapping on chromosome 9 in chronic myeloid leukemia cases bearing genomic deletions on der(9)

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Leukemia

• Publication date

  2009-04-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/leu.2008.311PMID 18987658
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• "Home-brew" FISH assay shows higher efficiency than BCR-ABL dual color, dual fusion probe in detecting microdeletions and complex rearrangements associated with t(9;22) in chronic myeloid leukemia.

  2007cited by this paper
• Size matters: the prognostic implications of large and small deletions of the derivative 9 chromosome in chronic myeloid leukemia.

  2006cited by this paper
• Imatinib mesylate therapy may overcome the poor prognostic significance of deletions of derivative chromosome 9 in patients with chronic myelogenous leukemia.

  2005cited by this paper
• The tumor suppressor PP2A is functionally inactivated in blast crisis CML through the inhibitory activity of the BCR/ABL-regulated SET protein.

  2005cited by this paper
• Imatinib improves but may not fully reverse the poor prognosis of patients with CML with derivative chromosome 9 deletions.

  2003cited by this paper
• Double jeopardy from a single translocation: deletions of the derivative chromosome 9 in chronic myeloid leukemia.

  2003cited by this paper
• Relative expression software tool (REST©) for group-wise comparison and statistical analysis of relative expression results in real-time PCR

  2002cited by this paper
• a powerful and independent prognostic indicator in chronic myeloid leukemia

  2001cited by this paper

• Expression signatures of intragenic miRNAs and their corresponding host genes in myeloid leukemia cells

  2012cites this paper
• Identification of copy number alterations by array comparative genomic hybridization in patients with late chronic or accelerated phase chronic myeloid leukemia treated with imatinib mesylate

  2011cites this paper
• Decreased TET2 gene expression during chronic myeloid leukemia progression.

  2011cites this paper
• Personal information First name ( s ) / Surname ( s )

  2007cites this paper